Browsing Tag
ublituximab-xiiy
2 posts
Why myasthenia gravis could become the next major test for TG Therapeutics’ BRIUMVI franchise
Find out how TG Therapeutics’ BRIUMVI myasthenia gravis data could expand its autoimmune growth story beyond multiple sclerosis.
Why anti-CD20 competition in multiple sclerosis is shifting toward real-world performance data
Discover why real-world data is reshaping anti-CD20 competition in MS and what it means for TG Therapeutics, Inc.’s BRIUMVI strategy. Read more.